Temporal hs-cTnT Increase Linked to Risk of CHD, CHF

This article originally appeared here.
Share this content:
Temporal hs-cTnT Increase Linked to Risk of CHD, CHF
Temporal hs-cTnT Increase Linked to Risk of CHD, CHF

THURSDAY, June 9, 2016 (HealthDay News) -- Temporal increases in high-sensitivity cardiac troponin T (hs-cTnT) are associated with increased risk of coronary heart disease (CHD), heart failure, and all-cause mortality, according to a study published online June 8 in JAMA Cardiology.

John W. McEvoy, M.B., B.Ch., from the Johns Hopkins Bloomberg School of Public Health in Baltimore, and colleagues conducted a prospective observational cohort study involving 8,838 participants with biracial representation who had hs-cTnT measured twice, six years apart. During a maximum of 16 years, the author examined the correlation between hs-cTnT change and subsequent CHD, heart failure, and death.

The researchers observed independent correlations for incident detectable hs-cTnT with subsequent CHD (hazard ratio [HR], 1.4), heart failure (HR, 2.0), and death (HR, 1.5), relative to an hs-cTnT level <0.005 ng/mL at both visits. Among individuals with the most marked hs-cTnT increases, the HRs were as high as 4.0 for CHD and death and 8.0 for heart failure. Among those with relative hs-cTnT reductions greater than 50 percent from baseline, the risk for subsequent outcomes was lower. Inclusion of information on hs-cTnT change improved discrimination for heart failure and death in a model that included traditional and other risk factors.

"Serial determination of hs-cTnT trajectory adds clinically relevant information to baseline testing and may be useful in prognostic assessments and the targeting of prevention strategies to high-risk individuals," the authors write.

Several authors disclosed financial ties to Roche Diagnostics, which donated reagents for the assays.

Abstract
Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Keytruda for All Cancers With Genetic Biomarker

FDA Approves Keytruda for All Cancers With Genetic ...

First medication sanctioned for any cancer, regardless of origin

Regular Chocolate Consumption May Lower Risk of A-Fib

Regular Chocolate Consumption May Lower Risk of A-Fib

13-year study finds lower odds for atrial fibrillation in people eating moderate amounts

Doctors Urged to Check Patient Drug History Before Opioid Rx

Doctors Urged to Check Patient Drug History Before ...

Opioid abuse down when physicians are legally obligated to check patient's drug history

is free, fast, and customized just for you!

Already a member?

Sign In Now »